Who are propan-2-ol's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Povidone Iodine Topical, Povidone-Iodine 0.3%, Lugols Strong Iodine, Iodophor 0.7% and IPA 74% w/w, Iodine povidone, Iodophor (10% povidone-iodine).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/propan-2-ol.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

propan-2-ol — Competitive Intelligence Brief

propan-2-ol (propan-2-ol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antiseptic/disinfectant. Area: Antiseptic/Disinfectant.

marketed Topical antiseptic/disinfectant Antiseptic/Disinfectant Small molecule Live · refreshed every 30 min

Target snapshot

propan-2-ol (propan-2-ol) — The Hong Kong Polytechnic University. Propan-2-ol is a simple aliphatic alcohol that acts as a solvent and disinfectant by denaturing proteins and disrupting microbial cell membranes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
propan-2-ol TARGET	propan-2-ol	The Hong Kong Polytechnic University	marketed	Topical antiseptic/disinfectant
Povidone Iodine Topical	Povidone Iodine Topical	Mary K Hayden	marketed	Topical antiseptic/disinfectant	Microbial cell membranes and proteins (non-selective)
Povidone-Iodine 0.3%	Povidone-Iodine 0.3%	Norwegian University of Science and Technology	marketed	Topical antiseptic/disinfectant
Lugols Strong Iodine	Lugols Strong Iodine	Jesús María Villar del Moral	marketed	Topical antiseptic/disinfectant	Microbial proteins and nucleic acids (non-specific oxidative mechanism)
Iodophor 0.7% and IPA 74% w/w	Iodophor 0.7% and IPA 74% w/w	Johns Hopkins University	marketed	Topical antiseptic/disinfectant
Iodine povidone	Iodine povidone	Montefiore Medical Center	marketed	Topical antiseptic/disinfectant
Iodophor (10% povidone-iodine)	Iodophor (10% povidone-iodine)	University of California, Irvine	marketed	Topical antiseptic/disinfectant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antiseptic/disinfectant class)

Corewell Health East · 1 drug in this class
Jesús María Villar del Moral · 1 drug in this class
Johns Hopkins University · 1 drug in this class
Mary K Hayden · 1 drug in this class
Montefiore Medical Center · 1 drug in this class
Norwegian University of Science and Technology · 1 drug in this class
The Hong Kong Polytechnic University · 1 drug in this class
University of California, Irvine · 1 drug in this class
University of California, Los Angeles · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). propan-2-ol — Competitive Intelligence Brief. https://druglandscape.com/ci/propan-2-ol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab